Projects

HTTK toob kokku juhtivad psüühika, keha, sotsiaalse konteksti ja ruumilise konteksti uurijad, et luua distsipliinide ülene arusaam komplekssüsteemidest, mis mõjutavad heaolu: elu kvaliteeti erinevates valdkondades objektiivses ja eriti subjektiivses mõttes. Me käsitleme 4 uurimisvaldkonda. 1) KORRELAADID: Millised bio-psühholoogilised ja sotsiaal-ruumilised omadused on seotud heaolu püsivamate komponentidega nagu eluga rahulolu? 2) MEHHANISMID: Kuidas rulluvad inimestes lahti heaolu dünaamilised komponendid, näiteks emotsioonid? 3) ENESEHOOL: Kuidas inimesed ise oma heaolu enesehoole ökosüsteemides mõistavad ja juhivad? 4) SEKKUMISED: Kuidas heaolu isikustatud ja kohandatud sekkumistega edendada? HTTK rahastab interdistsiplinaarseid ametikohti; registriandmetega lõimitud longituud-uuring; doktorikooli; tippsündmusi; ja rändluse ja koostöö toetusmeedet. HTTK tõstab osalevate rühmade, asutuste ja Eesti heaoluteaduste tulemuslikkust ja mõjukust.

This Centre of Excellence (CoE) focuses on fostering innovation in resource efficiency, promoting circular economy practices, utilizing local resources, ensuring safe material circulation, and educating researchers to reduce environmental impacts. It centers around four key areas: Strategic Mineral Resources (SMR), Carbon-Based Resources (CBR), Circular Technologies Upscaling (CTU), and Circular Business Eco-System and Modeling (CBEM). The SMR group maps critical materials in waste streams, including renewables, for extraction and reuse while minimizing hazardous waste. The CBR group develops eco-friendly pathways for essential chemicals and plastics, also assessing their environmental impact. The CTU group pioneers waste reduction and recycling methods for aqueous, and solid waste, incl. water purification. The CBEM group analyzes sustainable business ecosystems and value chains. This CoE's interdisciplinary approach will benefit both Estonia and Europe by advancing circular economy.

To sustain life and its quality on Earth, the EU has established several initiatives for the implementation of the Green Deal: Zero Pollution Action Plan, Farm to Fork and Green Deal Industrial Plan, among many others. All of these require significant innovation, based on new knowledge and skills – research, training and education – coupled with industry adaptation, civil society engagement and smart regulation, which is a challenge globally. More importantly, we need significantly more people who can carry out this innovation. The main objective of “Innovative Chemistry and Biotechnology for a Sustainable Future” (INNOCHEMBIO) is to train future experts of sustainable chemistry and biotechnology, helping Europe to take the next steps in the green transition. The solutions and trained experts can reduce the environmental impact of the chemical and agricultural industries, offer eco-friendly analytical techniques, and assess the safety of new materials. This will be achieved through interdisciplinary research projects in an international research environment, collaboration with the industry, the public sector and the civil society, via a comprehensive quadruple-helix based training programme. As a result, our graduates will not only become experts in their respective fields, but leaders and spokespersons. Eventually, through dedicated career planning, we provide skilled workforce to all 4 sectors of the helix. INNOCHEMBIO is an international consortium led by TalTech, with over 100 years of experience in chemistry and biotechnology research and training. INNOCHEMBIO will achieve its objectives by recruiting 15 PhD candidates in up to two calls offering fellowships for 48 months. During this period, the candidates will receive discipline specific training both in Estonia and abroad by working on their research project; broader training through courses offered at TalTech and by our partners; and experience working in the private sector.

Europe still sees a quarter of the world's cancer cases each year, making cancer the second leading cause of death and illness in the region after cardiovascular diseases. Unless we take decisive action, lives lost to cancer in the EU are set to increase by more than 24% by 2035, making it the leading cause of death in the EU. Cross-border collaboration can address this challenge by combining data from various modalities and sources, extracting meaningful insights to deepen our understanding of cancer. However, ethical, legal, and national regulations, along with data access processes, including differing interpretations of the EU GDPR create significant hurdles. Technical interoperability issues across European cancer RIs, and patients' and citizens' rights to control who uses their personal information and for what purposes further complicate data sharing. The project will provide European researchers, SMEs, and innovators with a decentralized collaborative network, “UNCAN-CONNECT,” for cancer research. It consists of both technical components, a governance, compliance, and operational framework based on the UNCAN blueprint, with the goal of operationalizing it. The objective is to facilitate access to cancer data, promote open science, and revolutionize cancer research and treatment by co-creating an open-source federation of federations platform. It will be developed using specific use cases focused on six major cancer types: Paediatric, Lymphoid malignancies, Pancreatic cancer, Ovarian, Lung, and Prostate cancers and active collaboration with a diverse range of stakeholders,including researchers, SMEs, industrial end users, and citizens. It will build on existing European RIs such as BBMRI as well as initiatives like EOSC4CANCER, CanSERV, EUCAIM, to enable seamless storage, access, sharing, and processing of data across Member States and associated countries. This approach will foster interoperability and collaboration, accelerating progress in cancer research. This action is part of the Cancer Mission clusters of projects 'Understanding' established in 2022.

Driving Climate Positive Futures (DREAM+PLAN), a truly interdisciplinary, international, and intersectoral PhD program, uniting European and Australian research via 32 doctoral positions, many for double degree. DREAM+PLAN brings together a community of visionary changemakers, leaders, who dream big and develop tangible pathways for solving local and global climate-related challenges, all united by a mission to create a positive impact, towards a more sustainable, fair, inclusive and thriving planet for future generations. The overarching objectives of DREAM+PLAN research training program is to create and deliver, legacy-worthy, novel, cutting-edge, 3i-centric training through best-practice multi-faceted, group and individual training options for DC’s

DigiBio project focuses on digitalisation, bioeconomy, and sustainability, scientific domains which constitute a high priority in national, regional, and EU strategies and policies. As the second large European Centre within this area, the Estonian Centre for Bioesustainability (ECB) will place Estonia in a very competitive position in European R&I. With DTU assistance, ECB will establish a major research, technology development, and innovation platform for the generation of cutting-edge bioengineering solutions focused on sustainable bio-production through biology digitalisation. This platform will accelerate lab-to-market translation of bioengineering solutions, diversifying Estonian national industry. DigiBio’s overarching objective is to establish a state-of-the-art CoE for digitalisation of biology in Estonia, through upgrading the ECB.

This multidisciplinary study aims to decrease cardiovascular mortality in Estonia by increasing treatment adherence and empowering patients to create a supportive self-management environment for monitoring their health and actively participating in the treatment process. Analysing 1) the LDL-cholesterol values of North Estonia Medical Centre (NEMC) patients to find underdiagnosed and undertreated patients and 2) treatment adherence to lipid-lowering drugs (LLD). Identifying patient groups who need additional support. During the pilot project, a novel application will be developed, together with personal support, used to increase LLD adherence. The novelty of the tool – combining the data used in Estonia from the Nationwide Health Information System, ePrescription, and NEMC electronic medical record with the data collected by the patient and enabling two-way communication between the patient and medical staff. In the last stage of the study, an impact assessment of the tool is planned.

This project aims to investigate how epigenetic mechanisms, specifically histone modifications, control gene expression during neuronal development and maturation. We recently discovered that histone bivalency, the simultaneous presence of two histone modifications with opposing functions, controls the timing of gene expression during the maturation of cerebellar neurons. In the proposed studies, we will examine the mechanisms and function of histone bivalency in the adult brain, as well as the species-specific differences in bivalency during mouse and human neuronal development. The research also aims to uncover the molecular mechanisms underlying neurodevelopmental diseases associated with mutations in EZH1, a key enzyme involved in the regulation of bivalent domains. This project will provide fundamental insights into the chromatin mechanisms of brain development and function, with potential implications for understanding and treating neurodevelopmental disorders.

This project aims to investigate how epigenetic mechanisms, specifically histone modifications, control gene expression during neuronal development and maturation. We recently discovered that histone bivalency, the simultaneous presence of two histone modifications with opposing functions, controls the timing of gene expression during the maturation of cerebellar neurons. In the proposed studies, we will examine the mechanisms and function of histone bivalency in the adult brain, as well as the species-specific differences in bivalency during mouse and human neuronal development. The research also aims to uncover the molecular mechanisms underlying neurodevelopmental diseases associated with mutations in EZH1, a key enzyme involved in the regulation of bivalent domains. This project will provide fundamental insights into the chromatin mechanisms of brain development and function, with potential implications for understanding and treating neurodevelopmental disorders.

Neural plasticity is the ability of nervous system to change its activity in response to stimuli by reorganizing its structure, functions, or connections and this is the main cellular basis for memory. Activity-regulated genes play crucial roles in the formation of neuronal plasticity, and dysregulation of this process gives rise to various nervous system disorders. The neurotrophin BDNF is among the best-studied activity-regulated genes, and its polymorphisms are associated with impairments in human cognition. Our results also place the basic helix-loop-helix transcription factor TCF4, that is implicated in a variety of psychiatric and autism spectrum disorders, to the group of activity-regulated transcription factors. The aim of this project is to study gene regulation in intellectual disability and autism spectrum disorders with emphasis on disease-associated transcription factors TCF4, SATB2, FOXP1, and neurotrophin BDNF for finding new drug targets.

The infrastructure brings together the capabilities in chemical synthesis, chemical and biotechnology in Estonia. Its primary goal is the development and technologization of new sustainable and environmentally friendly synthesis methods, such as mechanosynthesis, flow chemistry, electrochemistry, photochemistry, and organocatalysis. New chemical methods (using enzymes, ionic liquids, and metal-organic frameworks) creates new opportunities for obtaining complex natural compounds. To ensure the sustainability of methods and materials, safety studies are conducted. The shared use of the infrastructure initiates new interdisciplinary projects and creates prerequisites for innovation and collaboration with research-intensive companies. Involving the use of infrastructure at all levels of higher education and in micro-degree programs ensures continuity in science and a qualified personnel for entrepreneurship.

The project aims to advance Electric Propulsion Drive System (EPDS) Digital Twin (DT) technology for Software Defined Electric Vehicles (SDEVs), with a focus on achieving DT adaptive and intelligent levels. It addresses the need for efficient testing and evaluation of electric propulsion systems in line with EU clean energy transition goals. Leveraging the rapid development of DT technology, the project seeks to contribute to SDV technology through enhanced modeling, data gathering, IoT integration, and system optimization. Key challenges include lifecycle management, data processing, and real-time communication between physical and virtual systems. The project encompasses advanced modeling, data gathering, IoT, and communication infrastructure, system integration, optimization, and technology demonstration.

Wood is Estonia's most important bio-based raw material, the skilful processing of which creates high added value, carbon binding products. Today, Estonian universities do not have a unified action plan and infrastructure for coordinated research and development (R&D) and for offering industrial solutions throughout the entire value chain. Therefore, the infrastructure is created for linking 14 structural units of 8 institutes of 3 universities. This synergy enables to carry out interdisciplinary, high quality R&D activities of wood valorisation. The infrastructure creates new opportunities for training young researchers and provides a strong base for international cooperation. An integrated contact point will be created for effective marketing of services of the infrastructure. R&D of the infrastructure covers mechanical, chemical, biochemical and thermochemical valorisation of primary and secondary wood and can take the Estonian wood science and industry to a new development level.

Life-sustaining artificial kidney treatment or haemodialysis (HD) is needed for end-stage renal disease and critical care patients. High quality HD must ensure effective and personalized blood purification from harmful uremic toxins (UT), among inflammation-cardiovascular disease related middle size (MM)-UT. This, urged by a need for HD surveillance in crisis (coronavirus, war, energy), has created a demand for on-line, bloodless, and non-infectious tools for UT removal monitoring. Optical monitoring can provide a feasible tool for this. However, to date no reliable monitoring technology of MM-UTs is available. This project aims to fill this knowledge gap. Optical spectral signature identification combined with chromatographic and biochemical analyses to reveal the main optical MM markers in biofluids, selection of best signal processing algorithms, and a proof-of-concept in-vivo clinical study is planned to develop a novel optical technology for on-line MM-UT removal monitoring in HD.